Sign In
Buy LEGN
$19.13
+0.120 (+0.631%)
At Close: Aug 04, 2026
Week In Review: Genscript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse
02:52pm, Sunday, 16'th May 2021
Genscript raised more than $1 billion from Hillhouse Capital in several different investments, including a $500 million commitment to Genscript's Legend Biotech CAR-T subsidiary. Shanghai Fosun Pharma
Legend Biotech (LEGN) Stock: Over 10% Increase Pre-Market Explanation
07:32am, Friday, 14'th May 2021
The stock price of Legend Biotech Corp (NASDAQ: LEGN) increased by over 10% pre-market. This is why it happened.
Legend Biotech Reports New and Updated Data from BCMA CAR-T Program at 2021 ASCO and EHA Meetings
12:11pm, Wednesday, 12'th May 2021
SOMERSET, N.J.--(BUSINESS WIRE)---- $LEGN #ASCO21--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and developmen
Week In Review: CANbridge Licenses LogicBio's Adeno-Associated Virus For Gene Therapies In $591 Million Deal
05:29pm, Monday, 03'rd May 2021
CANbridge will make a $10 million upfront payment for the two Fabry and Pompe candidates. Guangzhou Link Health Pharma and Australia's George Clinical plan to form a China clinical CRO JV that will co
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
Legend Biotech Corporation (LEGN) CEO Ying Huang on Q4 2020 Results - Earnings Call Transcript
09:43am, Thursday, 18'th Mar 2021
Legend Biotech Corporation (LEGN) CEO Ying Huang on Q4 2020 Results - Earnings Call Transcript
Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update
07:00am, Thursday, 18'th Mar 2021
SOMERSET, N.J.--(BUSINESS WIRE)---- $LEGN #biotech--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and developme
Legend Biotech Announces Fourth Quarter and Full-Year 2020 Earnings Conference Call
04:30pm, Wednesday, 10'th Mar 2021
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
Biotech Shares Have Soared Since 2020's Wave of IPOs
09:45am, Wednesday, 17'th Feb 2021
Indicative of investors' enthusiasm for new biotechs, the average gain in share price for the top 10 companies of the sector that went public in 2020 now tops 100%.
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
SOMERSET, N.J.--(BUSINESS WIRE)-- #LegendBiotech--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and devel
Week In Review: Week's China Life Science Investments Total $800 Million
03:01pm, Sunday, 20'th Dec 2020
Overland Pharmaceuticals will form a $117 million China JV with Allogene Therapeutics to bring allogenic CAR-T drugs to China. Harbour BioMed has out-licensed its fully human SARS-CoV-2 neutralizing a
Legend Biotech to Participate in the 39th Annual J.P. Morgan Healthcare Conference
04:30pm, Tuesday, 15'th Dec 2020
SOMERSET, N.J.--(BUSINESS WIRE)-- #JPM2021--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development
Legend Biotech Added to the NASDAQ Biotechnology Index
04:30pm, Monday, 14'th Dec 2020
SOMERSET, N.J.--(BUSINESS WIRE)-- #biotech--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development
SOMERSET, N.J.--(BUSINESS WIRE)-- #LYMSM--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development o
